Author Correction: Dapagliflozin in heart failure with improved ejection fraction: a prespecified analysis of the DELIVER trial

被引：0
|
作者：
Orly Vardeny
James C. Fang
Akshay S. Desai
Pardeep S. Jhund
Brian Claggett
Muthiah Vaduganathan
Rudolf A. de Boer
Adrian F. Hernandez
Carolyn S. P. Lam
Silvio E. Inzucchi
Felipe A. Martinez
Mikhail N. Kosiborod
David DeMets
Eileen O’Meara
Shelley Zieroth
Josep Comin-Colet
Jaroslaw Drozdz
Chern-En Chiang
Masafumi Kitakaze
Magnus Petersson
Daniel Lindholm
Anna Maria Langkilde
John J. V. McMurray
Scott D. Solomon
机构：
[1] University of Minnesota,Minneapolis VA Center for Care Delivery and Outcomes Research
[2] University of Utah Medical Center,BHF Glasgow Cardiovascular Research Center, School of Cardiovascular and Metabolic Health
[3] Cardiovascular Division, Department of Cardiology, Thoraxcenter
[4] Brigham and Women’s Hospital,Cardiology Department
[5] Harvard Medical School,Department Cardiology
[6] University of Glasgow,General Clinical Research Center and Division of Cardiology
[7] Erasmus Medical Center,undefined
[8] Duke University Medical Center,undefined
[9] National Heart Centre Singapore and Duke–National University of Singapore,undefined
[10] Yale School of Medicine,undefined
[11] Universidad Nacional de Córdoba,undefined
[12] Saint Luke’s Mid America Heart Institute and University of Missouri-Kansas City,undefined
[13] University of Wisconsin,undefined
[14] Montreal Heart Institute and Université de Montréal,undefined
[15] St. Boniface Hospital & University of Manitoba,undefined
[16] Bellvitge University Hospital,undefined
[17] Bio-Heart Bellvitge Institute for Biomedical Research,undefined
[18] University of Barcelona,undefined
[19] Hospitalet de Llobregat,undefined
[20] Medical University Lodz,undefined
[21] Taipei Veterans General Hospital and National Yang Ming Chiao Tung University,undefined
[22] Kinshukai Hanwa Daini Senboku Hospital,undefined
[23] Late-Stage Development,undefined
[24] Cardiovascular,undefined
[25] Renal,undefined
[26] and Metabolism,undefined
[27] BioPharmaceuticals R&D,undefined
[28] AstraZeneca,undefined
来源：
Nature Medicine | 2023年 / 29卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：3269 / 3269
相关论文
共 50 条
  • [31] Dapagliflozin and Apparent Treatment-Resistant Hypertension in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: The DELIVER Trial
    Ostrominski, John W.
    Vaduganathan, Muthiah
    Selvaraj, Senthil
    Claggett, Brian L.
    Miao, Zi Michael
    Desai, Akshay S.
    Jhund, Pardeep S.
    Kosiborod, Mikhail N.
    Lam, Carolyn S. P.
    Inzucchi, Silvio E.
    Martinez, Felipe A.
    de Boer, Rudolf A.
    Hernandez, Adrian F.
    Shah, Sanjiv J.
    Petersson, Magnus
    Maria Langkilde, Anna
    Mcmurray, John J. V.
    Solomon, Scott D.
    CIRCULATION, 2023, 148 (24) : 1945 - 1957
  • [32] The cost-effectiveness of dapagliflozin in heart failure with preserved or mildly reduced ejection fraction: a European health-economic analysis of the DELIVER trial
    Booth, David
    Davis, Jason A.
    McEwan, Phil
    Solomon, Scott D.
    McMurray, John J. V.
    De Boer, Rudolf A.
    Comin-Colet, Josep
    Bachus, Erasmus
    Chen, Jieling
    EUROPEAN JOURNAL OF HEART FAILURE, 2023, 25 (08) : 1386 - 1395
  • [33] Effect of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction treated with beta-blockers: the DELIVER trial
    Peikert, A.
    Bart, B. A.
    Vardeny, O.
    Vaduganathan, M.
    Claggett, B. L.
    Desai, A. S.
    Jhund, P. S.
    Kosiborod, M. N.
    Lam, C. S. P.
    Martinez, F. A.
    De Boer, R. A.
    Hernandez, A. F.
    Shah, S. J.
    Mc Murray, J. J. V.
    Solomon, S. D.
    EUROPEAN HEART JOURNAL, 2023, 44
  • [34] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Giorgio Colombo
    Rosa Casella
    Alessia Cazzaniga
    Chiara Casiraghi
    Internal and Emergency Medicine, 2020, 15 : 515 - 517
  • [35] Dapagliflozin in patients with heart failure and reduced ejection fraction
    Colombo, Giorgio
    Casella, Rosa
    Cazzaniga, Alessia
    Casiraghi, Chiara
    INTERNAL AND EMERGENCY MEDICINE, 2020, 15 (03) : 515 - 517
  • [36] Dapagliflozin for patients with heart failure and reduced ejection fraction
    Ferry, Abigail
    JAAPA-JOURNAL OF THE AMERICAN ACADEMY OF PHYSICIAN ASSISTANTS, 2022, 35 (09): : 51 - 53
  • [37] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    McMurray, J. J. V.
    Solomon, S. D.
    Inzucchi, S. E.
    Kober, L.
    Kosiborod, M. N.
    Martinez, F. A.
    Ponikowski, P.
    Sabatine, M. S.
    Anand, I. S.
    Belohlavek, J.
    Bohm, M.
    Chiang, C. -E.
    Chopra, V. K.
    de Boer, R. A.
    Desai, A. S.
    Diez, M.
    Drozdz, J.
    Dukat, A.
    Ge, J.
    Howlett, J. G.
    Katova, T.
    Kitakaze, M.
    Ljungman, C. E. A.
    Merkely, B.
    Nicolau, J. C.
    O'Meara, E.
    Petrie, M. C.
    Vinh, P. N.
    Schou, M.
    Tereshchenko, S.
    Verma, S.
    Held, C.
    DeMets, D. L.
    Docherty, K. F.
    Jhund, P. S.
    Bengtsson, O.
    Sjostrand, M.
    Langkilde, A. -M.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21): : 1995 - 2008
  • [38] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
    Borghi, Claudio
    Cicero, Arrigo F. G.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (10): : 972 - 972
  • [39] Decline in Estimated Glomerular Filtration Rate After Dapagliflozin in Heart Failure With Mildly Reduced or Preserved Ejection Fraction: A Prespecified Secondary Analysis of the DELIVER Randomized Clinical Trial (vol 9, pg 144, 2024)
    Magnani, Jared W.
    Allen, Norrina B.
    JAMA CARDIOLOGY, 2024, 9 (07) : 674 - 674
  • [40] Influence of background therapy on efficacy of dapagliflozin in patients with heart failure and improved ejection fraction
    Porras, M. A. Pabon
    Clagget, B. L.
    Chatur, S.
    Bhatt, A. S.
    Vaduganathan, M.
    Fang, J.
    Desai, A.
    Jhund, P.
    Martinez, F.
    De Boer, R.
    Kosiborod, M.
    Lam, C.
    Mcmurray, J.
    Solomon, S.
    Vaderny, O.
    EUROPEAN HEART JOURNAL, 2023, 44
12345